Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Southern California, Los Angeles, California, United States

Study leads

Ali Moiin, MD
Study Director
SciTech Development, Inc.

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Advanced Solid Tumor · Cutaneous Tumor · Subcutaneous Tumor

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States · Boston, United States

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

Advanced or Metastatic Solid Tumors · Non Small Cell Lung Cancer · NSCLC

Abroad (travel likely)RecruitingPHASE1

Scottsdale, United States · New Haven, United States

TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors

Nonsmall Cell Lung Cancer · Solid Tumor, Adult

Abroad (travel likely)RecruitingPHASE1

Guanzhou, China

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States